Imagion Announces New CEO
June 19, 2023
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, is pleased to announce it has appointed Isaac
Category: Events & Webinars
Chairman’s Address to Shareholders and Q&A Session at 2023 Annual General Meeting
May 25, 2023
Imagion Biosystems’ Chairman’s address to shareholders at the 2023 Annual General Meeting. PDF of the 2023 AGM Presentation Deck Watch the AGM 2023 Q&A Session
Imagion presents MagSense® interim study results at breast cancer meeting
December 8, 2022
Imaging agent aids in resolving nodal status MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of
2022 Switzer Small & Micro Cap Conference Presentation
September 29, 2022
Imagion Bio CEO, Robert Proulx, presents company information to investors at the 2022 Switzer Small & Micro Cap Conference in September. Video Transcript: Thank you,
Imagion to Present Prostate Cancer Research Data at WMIC 2022
September 28, 2022
https://youtu.be/iH0a08glQYo Imagion to present prostate cancer research data at World Molecular Imaging Congress MagSense® molecular imaging agent shows high specificity and selectivity MELBOURNE — Imagion
Iron Oxide Nanoparticles in Lipid Delivery System May Lead to Better Cancer Treatment
June 20, 2022
Lipids are frequently used to form drug carrying nanoparticles because of their favorable biocompatibility. However, construction of such drug-carrying lipid nanoparticles often involves multiple steps.
Q&A Session at 2022 Annual General Meeting
June 10, 2022
Imagion Biosystems recording of the Q&A session at the 2022 Annual General Meeting. Imagion Biosystems’ board of directors answer questions from shareholders at the AGM
Presentation Visuals from 25th May 2022 Annual General Meeting
May 25, 2022
The presentation visuals from the 25th May 2022 Annual General Meeting are now available. You can find the 2022 AGM Investor Presentation here. Other
Chairman’s Address to Shareholders at 2022 Annual General Meeting
May 25, 2022
Imagion Biosystems recording and transcript of the Chairman’s address to shareholders at the 2022 Annual General Meeting. Dear Shareholders, It is my pleasure to
Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting
November 27, 2021
As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems’ President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as imaging